Detalhe da pesquisa
1.
Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
Eur J Clin Microbiol Infect Dis
; 42(4): 481-491, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820931
2.
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay.
Ann Hepatol
; 28(4): 101097, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030570
3.
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management.
Ann Hepatol
; 19(4): 396-403, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418749
4.
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
J Hepatol
; 62(5): 1056-60, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25481567
5.
Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections?
J Antimicrob Chemother
; 59(1): 140-3, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17079239